One dollar or less used to be the common threshold for what we call "penny stocks." Today, the SEC has expanded penny stocks to securities that trade for less than $5 a share. Many investors avoid these stocks because they are speculative in nature. Meanwhile, penny stocks often trade infrequently and hold wide bid/ask spreads. These stocks also carry many other traits that, in many cases, cause excessive volatility. With that said, some penny stocks perform incredibly well, which helps them remain attracti ...

CERRITOS, Calif., July 07, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI") (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, announced today that it has repaid its $86 Million senior secured convertible note with Deerfield Partners through a debt refinancing that includes new credit facilities from OrbiMed. This transaction is intended to increase liquidity, improve operating flexibility and extend debt maturities. Under the new financing arrangements with Orb ...

核心观点 - 分析师认为Oncology Institute, Inc. (TOI)是医疗设施股中最佳买入标的之一，基于其社区肿瘤护理平台的增长前景以及分析师对其股价上行空间的看好 [1][2] 分析师观点与评级 - 在筛选的医疗设施股中，TOI基于分析师平均预测的上行空间排名第一，分析师预计其股价约有46.8%的上涨空间 [1] - Needham于6月17日将该股目标价从5美元上调至7美元，并维持买入评级 [1] - BTIG于6月8日将该股目标价从7美元上调至8美元，同样维持买入评级 [1] - 近期分析师上调目标价表明对该平台增长前景的信心 [2] 公司业务与投资逻辑 - 公司通过诊所和附属机构在美国多个州提供社区肿瘤护理服务 [3] - 公司的投资逻辑取决于其社区肿瘤平台能否在扩大基于价值的癌症护理规模的同时，减少亏损并改善现金流生成 [2] - 公司规模仍小于大型医院运营商，且风险更高 [2]